SM BIOMED
SM BIOMED, headquartered in Malaysia, is a leading player in the biomedical industry, specialising in innovative healthcare solutions. Founded in 2010, the company has established a strong presence across Southeast Asia, focusing on the development and distribution of advanced medical devices and diagnostic tools. With a commitment to quality and innovation, SM BIOMED offers a range of unique products, including cutting-edge laboratory equipment and patient monitoring systems. Their dedication to research and development has positioned them as a trusted partner in the healthcare sector, recognised for their contributions to improving patient outcomes. Notable achievements include strategic partnerships with healthcare institutions and a growing portfolio of patented technologies, solidifying SM BIOMED's reputation as a pioneer in the biomedical field. As they continue to expand their market reach, SM BIOMED remains dedicated to enhancing healthcare through science and technology.
DitchCarbon Score
How does SM BIOMED's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SM BIOMED's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SM BIOMED's reported carbon emissions
SM BIOMED, headquartered in Malaysia (MY), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many organisations in the biomedical sector are increasingly focusing on sustainability and climate commitments. This includes setting science-based targets and engaging in initiatives aimed at reducing their carbon footprint across all scopes of emissions. As the industry evolves, SM BIOMED may consider establishing measurable climate commitments to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SM BIOMED is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
